Does MESALAMINE Cause Focal segmental glomerulosclerosis? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Focal segmental glomerulosclerosis have been filed in association with MESALAMINE (Mesalamine). This represents 0.1% of all adverse event reports for MESALAMINE.
17
Reports of Focal segmental glomerulosclerosis with MESALAMINE
0.1%
of all MESALAMINE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From MESALAMINE?
Of the 17 reports, 5 (29.4%) required hospitalization.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MESALAMINE. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does MESALAMINE Cause?
Drug ineffective (4,753)
Off label use (2,450)
Colitis ulcerative (2,427)
Diarrhoea (1,874)
Condition aggravated (1,838)
Pyrexia (1,467)
Haematochezia (1,456)
Fatigue (1,442)
Headache (1,435)
Pain (1,395)
What Other Drugs Cause Focal segmental glomerulosclerosis?
TACROLIMUS (339)
MYCOPHENOLATE MOFETIL (181)
PREDNISONE (173)
CYCLOSPORINE (96)
METHYLPREDNISOLONE (81)
PREDNISOLONE (73)
RITUXIMAB (73)
BASILIXIMAB (67)
OMEPRAZOLE (60)
LANSOPRAZOLE (55)
Which MESALAMINE Alternatives Have Lower Focal segmental glomerulosclerosis Risk?
MESALAMINE vs MESNA
MESALAMINE vs METAMIZOLE
MESALAMINE vs METARAMINOL
MESALAMINE vs METAXALONE
MESALAMINE vs METFORMIN